首页> 美国卫生研究院文献>Journal of the Boston Society of Medical Sciences >Novel Protective Effects of Stem Cell Factor in a Murine Model of Acute Septic Peritonitis
【2h】

Novel Protective Effects of Stem Cell Factor in a Murine Model of Acute Septic Peritonitis

机译:干细胞因子在急性败血症性腹膜炎小鼠模型中的新型保护作用。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Mast cells participate in the host response during sepsis and have been shown to have a protective effect in a murine model of acute septic peritonitis and multi-organ failure initiated by cecal ligation and puncture (CLP). Stem cell factor (SCF) is a hematopoietic cytokine important in mast cell proliferation and activation. In the present study, we examined the protective effects of a single intraperitoneal injection of SCF given 2 hours before CLP surgery in mice. Four days after the CLP surgery, SCF pretreatment significantly improved mouse survival from 29 to 56% and mast cells were absolutely required for this effect. Immunoneutralization studies revealed that the SCF-stimulated release of monocyte chemoattractant protein-1 (MCP-1) into the septic peritoneal cavity contributed to the protective effect of SCF in this model. One potential cellular source of MCP-1 was the SCF-activated mast cell. In addition, SCF pretreatment significantly augmented circulating levels of SCF and the immunomodulatory cytokine interleukin-10 in septic mice, in part because the SCF pretreatment seemed to promote the release of both mediators from the liver. Additional hepatic effects of SCF treatment included an accelerated expression of hepatic levels of signal transducer and activator of transcription-3 (STAT-3) in CLP mice pretreated with SCF. Taken together, the findings from the present study demonstrate that the intraperitoneal delivery of SCF has a major protective effect in a murine model of CLP.
机译:肥大细胞参与败血症过程中的宿主反应,并已显示出在急性败血症性腹膜炎和盲肠结扎穿刺(CLP)引发的多器官衰竭的小鼠模型中具有保护作用。干细胞因子(SCF)是在肥大细胞增殖和激活中重要的造血细胞因子。在本研究中,我们检查了在CLP手术前2小时给予腹腔注射SCF的保护作用。 CLP手术后四天,SCF预处理可将小鼠存活率从29%显着提高到56%,并且肥大细胞绝对是实现此效果所必需的。免疫原化研究表明,SCF刺激单核细胞趋化蛋白1(MCP-1)释放到脓毒症腹膜腔中有助于SCF在该模型中的保护作用。 MCP-1的一种潜在细胞来源是SCF激活的肥大细胞。此外,SCF预处理可显着增加败血症小鼠的SCF循环水平和免疫调节细胞因子白介素10,部分原因是SCF预处理似乎促进了肝脏中两种介质的释放。 SCF治疗的其他肝功能包括在用SCF预处理的CLP小鼠中肝水平信号转导和转录激活因子3(STAT-3)的加速表达。综上所述,本研究的结果表明,腹膜内递送SCF在CLP鼠模型中具有主要的保护作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号